Pure Global AI
ANVISA registration 80134860307Valid until Mar 18, 2034

IMMUNOHEMATOLOGY - RH-HR, KELL, KIDD, DUFFY - MONOCLONAL ORIGIN

ANVISA Registration Number: 80134860307GRIFOLS BRASIL LTDAPROGENIKA BIOPHARMA S.L.Risk Class IV
Verified
Device names
Technical name
IMMUNOHEMATOLOGY - RH-HR, KELL, KIDD, DUFFY - MONOCLONAL ORIGIN
View exact technical-name matches →
PT: IMUNOHEMATOLOGIA - RH-HR, KELL, KIDD, DUFFY - ORIGEM MONOCLONAL
Commercial name
ID RHD XT REAGENTES
View exact commercial-name matches →
Risk class
Class IV
Registration details
Registration Number
80134860307
Process Number
25351607686202229
CNPJ
02513899000171
Company information
Registration Holder
GRIFOLS BRASIL LTDA
Manufacturer
PROGENIKA BIOPHARMA S.L.
Manufacturing Country
Spain
PT: ESPANHA
Dates and status
Publication Date
Mar 18, 2024
Validity
18/03/2034
Last Updated
08/18/2026 19:00:00
About this record

Access comprehensive regulatory information for IMMUNOHEMATOLOGY - RH-HR, KELL, KIDD, DUFFY - MONOCLONAL ORIGIN in Brazil's medical device market through Pure Global AI's free database. This Risk Class IV medical device is registered under ANVISA number 80134860307 and manufactured by PROGENIKA BIOPHARMA S.L.. The registration is held by GRIFOLS BRASIL LTDA with validity until Mar 18, 2034.

This page shows the facts attached to this official registry row. Exact-name links return deterministic registry matches; open-ended comparison and market analysis are handed to AI Search with this record's context, without asserting that similar names represent the same entity.